2D Nanozymes Modulate Gut Microbiota and T‐Cell Differentiation for Inflammatory Bowel Disease Management
Advanced Healthcare Materials · 2024-02 · 13 (4)
DOI: 10.1002/adhm.202302576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.11.2023. Verfasst von Kai Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Polyethylenes, Polypropylenes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Provincial Natural Science Foundation, Research Fund of Anhui Institute of translational medicine.
Abstract (Originalsprache)
Intestinal commensal microbiota dysbiosis and immune dysfunction are significant exacerbating factors in inflammatory bowel disease (IBD). To address these problems, Pluronic F‐127‐coated tungsten diselenide (WSe 2 @F127) nanozymes are developed by simple liquid‐phase exfoliation. The abundant valence transitions of elemental selenium (Se 2− /Se 4+ ) and tungsten (W 4+ /W 6+ ) enable the obtained WSe 2 @F127 nanozymes to eliminate reactive oxygen/nitrogen species. In addition, the released tungsten ions are capable of inhibiting the proliferation of Escherichia coli . In a model of dextran sodium sulfate‐induced colitis, WSe 2 @F127 nanozymes modulate the gut microbiota by increasing the abundance of bacteria S24‐7 and significantly reducing the abundance of Enterobacteriaceae. Moreover, WSe 2 @F127 nanozymes inhibit T‐cell differentiation and improve intestinal immune barrier function in a model of Crohn's disease. The WSe 2 @F127 nanozymes effectively alleviate IBD by reducing oxidative stress damage, modulating intestinal microbial populations, and remodeling the immune barrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.
- Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
- School of Biomedical Engineering, Anhui Medical University, Hefei, 230022, China.
ORCID-Profile: Zhaohua Miao
Förderung
- National Natural Science Foundation of China
- Anhui Provincial Natural Science Foundation
- Research Fund of Anhui Institute of translational medicine
- Natural Science Foundation of Anhui Province
Zitieren
APA
Jiang, K., Cao, X., Wu, H., Xu, Y., Liu, L., Qian, H., Miao, Z., Wang, H., & Ma, Y. (2024). 2D Nanozymes Modulate Gut Microbiota and T‐Cell Differentiation for Inflammatory Bowel Disease Management. Advanced Healthcare Materials, 13(4). https://doi.org/10.1002/adhm.202302576
Vancouver
Jiang K, Cao X, Wu H, Xu Y, Liu L, Qian H, et al. 2D Nanozymes Modulate Gut Microbiota and T‐Cell Differentiation for Inflammatory Bowel Disease Management. Advanced Healthcare Materials. 2024;13(4). doi:10.1002/adhm.202302576
BibTeX
@article{Jiang2024,
author = {Jiang, Kai and Cao, Xiangjing and Wu, Haitao and Xu, Yifeng and Liu, Lulu and Qian, Haisheng and Miao, Zhaohua and Wang, Hua and Ma, Yan},
title = {2D Nanozymes Modulate Gut Microbiota and T‐Cell Differentiation for Inflammatory Bowel Disease Management},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {4},
doi = {10.1002/adhm.202302576}
}
EUVIMED